Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Warren Olanow

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
The Lancet. Neurology|July 10, 2003
Dietary vitamin E and Parkinson's disease: something to chew onC Warren Olanow
Rinsho Shinkeigaku = Clinical Neurology|December 1, 2012
[Medical therapy for Parkinson's disease--the current state of the art]C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|April 17, 2019
Levodopa is the best symptomatic therapy for PD: Nothing more, nothing lessC Warren Olanow
Neurology|February 18, 2009
Can we achieve neuroprotection with currently available anti-parkinsonian interventions?C Warren Olanow
Neurology|June 9, 2004
Melvin David Yahr, MD (1917-2004)C Warren Olanow
Annual Review of Medicine|January 30, 2004
The scientific basis for the current treatment of Parkinson's diseaseC Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2008
Levodopa/dopamine replacement strategies in Parkinson's disease--future directionsC Warren Olanow
Neurology|May 24, 2006
Rationale for considering that propargylamines might be neuroprotective in Parkinson's diseaseC Warren Olanow
Nature Reviews. Neurology|March 26, 2014
Parkinson disease: Gene therapy for Parkinson disease--a hope, or a dream?C Warren Olanow
Neurology|September 25, 2003
Present and future directions in the management of motor complications in patients with advanced PDC Warren Olanow
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
The Lancet. Neurology|July 10, 2003
Dietary vitamin E and Parkinson's disease: something to chew onC Warren Olanow
Rinsho Shinkeigaku = Clinical Neurology|December 1, 2012
[Medical therapy for Parkinson's disease--the current state of the art]C Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|April 17, 2019
Levodopa is the best symptomatic therapy for PD: Nothing more, nothing lessC Warren Olanow
Neurology|February 18, 2009
Can we achieve neuroprotection with currently available anti-parkinsonian interventions?C Warren Olanow
Neurology|June 9, 2004
Melvin David Yahr, MD (1917-2004)C Warren Olanow
Annual Review of Medicine|January 30, 2004
The scientific basis for the current treatment of Parkinson's diseaseC Warren Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2008
Levodopa/dopamine replacement strategies in Parkinson's disease--future directionsC Warren Olanow
Neurology|May 24, 2006
Rationale for considering that propargylamines might be neuroprotective in Parkinson's diseaseC Warren Olanow
Nature Reviews. Neurology|March 26, 2014
Parkinson disease: Gene therapy for Parkinson disease--a hope, or a dream?C Warren Olanow
Neurology|September 25, 2003
Present and future directions in the management of motor complications in patients with advanced PDC Warren Olanow
Pageof 19